Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Novel Therapeutic Approach by Nicotine in Experimental Model of Multiple Sclerosis.
Diazepam Inhibits Proliferation of Lymph Node Cells Isolated from Rats with Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Assessment of urinary incontinence in the women in Eastern Turkey.
Nogo Receptor Signaling Restricts Adult Neural Plasticity by Limiting Synaptic AMPA Receptor Delivery.
Safety of TNF inhibitors in adolescents and children.
Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis.
The Incidence, Prevalence, Costs and Impact on Disability of Common Conditions Requiring Rehabilitation in the US: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain.
Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly receiving selective serotonin-reuptake inhibitors.
Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?
Increased expression of Aquaporin 4 in the rat hippocampus and cortex during trimethyltin-induced neurodegeneration.
Cognitive motor interference during walking in multiple sclerosis using an alternate letter alphabet task.
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy.
Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis.
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis.
Patulous eustachian tube after percutaneous balloon microcompression for trigeminal neuralgia: case report.
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
Pathogenesis of immune-mediated neuropathies.
An MRI review of acquired corpus callosum lesions.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
Cognitive assessment in MS.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
PS3-16: Access and Collaboration with the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH).
Age-related changes in spleen of Dark Agouti rats immunized for experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
422
423
424
425
426
427
428
429
430
…
next ›
last »